Director
Current
Jan 2022 - Present
AeroLeads people directory · profile
Adriel C. Email & Phone Number
Scientist and investor
at
C.M. Capital Advisors
LinkedIn matched
✓ Verified May 2026
3 data sources
Profile completeness 100%
Current company
Role
Scientist and investor
Location
San Francisco, California, United States
Who is Adriel C.? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Adriel C. is listed as Scientist and investor at C.M. Capital Advisors, based in San Francisco, California, United States. AeroLeads shows a matched LinkedIn profile for Adriel C..
Adriel C. previously worked as Director at C.M. Capital Advisors and Director at C.M. Capital Corporation. Adriel C. holds M.S. In Management, Business Administration And Management, General from Stanford University Graduate School Of Business.
Company email context
Email format at C.M. Capital Advisors
This section adds company-level context without repeating Adriel C.'s masked contact details.
C.M. Capital Advisors
Review company-level records connected to Adriel C. before choosing the right outreach path.
Profile bio
About Adriel C.
Scientist, corporate strategist, and early stage investor driven to solve complex human health problems by leveraging cross-functional teams and leading-edge technologies. Adriel works helping companies define their corporate strategy as well as identify value creating opportunities. He has spearheaded financing, communications, and commercial development. Helped secure Forty Seven’s first venture capital investor which led to the biotech's IPO (FTSV, purchased by GILD). His research, focused on the immune system and oncology, has led to multiple clinical trials. Adriel is passionate about advancing the latest scientific and clinical research to create treatments for patients. He is a Sloan Fellow from Stanford Graduate School of Business, has a Ph.D. from Baylor University in Immunology and a B.S. from USC in public health.
Listed skills include Laboratory, Cell Biology, Western Blotting, Immuno Oncology, and 20 others.
Current workplace
Adriel C.'s current company
Company context helps verify the profile and gives searchers a useful next step.
15 roles
Adriel C. work experience
A career timeline built from the work history available for this profile.
Director
Current
Jan 2022 - Present
Corporate Development And Operations
Developed the corporate strategy plan with the executive team. Leads development of Orca's first cGMP commercial manufacturing facility from site selection and design through construction.
Jan 2021 - Jun 2022
Life Science Specialist
Dedicated to the life science practice of a global strategic consulting firm, advising large and small biopharma / diagnostic clients on their key strategic issues, using analytical rigor to help provide informed and actionable insights.
Oct 2019 - Dec 2019
Manager Of Corporate Development
Forty Seven (FTSV) and it’s leadIng antibody magrolimab was acquired by Gilead (GILD). Secured initial venture capital investor in a $75M Series A round. Completed submission of S-1 which resulted in a successful IPO. Spearheaded commercial development plans for lead drug candidate across multiple indications. Managed and delivered on time multiple.
Jun 2016 - Jul 2018
Postdoctoral Fellow
Developed a rigorous biomarker and sample management plan for two successfully filed IND applications as the Translational Research Lead. Co-managed the CD47 R&D team ensuring all in vivo and in vitro IND enabling studies were completed with our lead drug candidate, on the CIRM Disease Team grant for $20M. Led application and project managed all of.
Jan 2016 - May 2016
Doctoral Candidate
Primary reseach on colon and pancreas cancers, understanding the role of anti-CD47 combination therapies with checkpoint inhibitors and cancer targeting antibodies with in vivo models.
Jun 2012 - Jan 2016
Predoctoral Candidate
Worked on development of a novel tolerizing DC-based vaccine and role of microRNAs in multiple sclerosis.
Aug 2010 - Jun 2012
Life Science Researcher
Irv Weissman Laboratory at the Institute of Stem Cell Biology and Regenerative Medicine. Investigated CD96, a novel leukemic stem cell marker, and its potential as an antibody therapy in AML and in non-myeloablative bone marrow transplant conditioning. Helped develope antibody libraries for CD47 and other leukemia targets.
Apr 2008 - Aug 2010
Venture Analyst
Charter Life Science
Performed primary literature analysis and called key opinion leaders in neurology, gastroenterology, and cardiovascular disease to evaluate early stage life science deals.
Jul 2007 - Aug 2007
Undergraduate Researcher
Lesslie Weiner Lab. Neural stem cell characterization.
Jan 2007 - May 2007
Undergraduate Researcher
Garry Fathman lab. Treg cells. T-cell lineage.
May 2006 - Aug 2006
Summer Intern
Bayhill Therapeutics, Inc.
Administration of DNA encoding the mouse proinflammatory cytokine, osteopontin, in 100 EAE mice to observe any decreases the severity of autoimmune demyelinating disease by enhancing the TH2 nature of the T cell response.
Jan 2003 - Jun 2003
Database Analyist Intern
Formerly Metabolex. Helped a diabetes R&D company organize and identify key compounds from recently acquired intellectual property.
Jul 2002 - Aug 2002
Intern
Clinical Research: Worked under Dr. Emmett T. Cunningham, Jr. compiling statistics from patient histories dating back to the 1950s. Paper: Chronic Anterior Uveitis: An Infrequently Recognized Form of HLA-B27-Associated Uveitis in Female Patients by Bruno Castelo Branco, MD, Anna Hovakimyan, MD, Adriel CJ Cha, and Emmett Cunningham, MD, PhD, MPH. American.
Jul 2001 - Aug 2001
5 education records
Adriel C. education
M.S. In Management, Business Administration And Management, General
Stanford University Graduate School Of Business
Transitional Postdoc, Oncology And Cancer Biology
Stanford University School Of Medicine
Ph.D., Biomedical Studies In Immunology
Baylor University
B.S., Health Promotion & Disease Prevention
University Of Southern California
Education record
Stanford University Graduate School Of Business
FAQ
Frequently asked questions about Adriel C.
Quick answers generated from the profile data available on this page.
What company does Adriel C. work for?
Adriel C. works for C.M. Capital Advisors.
What is Adriel C.'s role at C.M. Capital Advisors?
Adriel C. is listed as Scientist and investor at C.M. Capital Advisors.
Where is Adriel C. based?
Adriel C. is based in San Francisco, California, United States while working with C.M. Capital Advisors.
What companies has Adriel C. worked for?
Adriel C. has worked for C.M. Capital Advisors, C.M. Capital Corporation, Orca Bio, L.E.K. Consulting, and Forty Seven Inc..
How can I contact Adriel C.?
You can use AeroLeads to view verified contact signals for Adriel C. at C.M. Capital Advisors, including work email, phone, and LinkedIn data when available.
What schools did Adriel C. attend?
Adriel C. holds M.S. In Management, Business Administration And Management, General from Stanford University Graduate School Of Business.
What skills is Adriel C. known for?
Adriel C. is listed with skills including Laboratory, Cell Biology, Western Blotting, Immuno Oncology, Antibodies, Clinical Research, Data Analysis, and Cell.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial